Cadwalader advised Population Health Investment Co. on the deal, while Davis Polk advised the sole book-running manager.
Population Health Investment Co., Inc. (Nasdaq: PHICU) executed its $150 million initial public offering of 15,000,000 units at a price of $10.00 per unit. The offering was priced on November 17 and is expected to close November 20.
Population Health Investment Co., Inc. is a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While Population Health may pursue an initial business combination in any industry, sector, or geographic region, it intends to focus on companies or divisions of companies in the healthcare industry, and in particular the therapeutics sector, in the United States and other developed countries. The company was founded by Dr. Clive Meanwell and Ian Read.
The Cadwalader team included Corporate partner Greg Patti (Picture) and associates Frank Bozzi and Erica Hogan and Tax partner Jason Schwartz and associate Matthew Seitz.
Davis Polk advised J.P. Morgan Securities LLC with a team including partners Deanna L. Kirkpatrick and Roshni Banker Cariello and associates Gil Savir and Lia-Michelle Keane. The tax team included partner Michael Farber and associate Eitan Ulmer. Counsel Marcie A. Goldstein provided FINRA advice.
Involved fees earner: Frank Bozzi – Cadwalader Wickersham & Taft; Erica Hogan – Cadwalader Wickersham & Taft; Gregory Patti – Cadwalader Wickersham & Taft; Jason Schwartz – Cadwalader Wickersham & Taft; Matthew Seitz – Cadwalader Wickersham & Taft; Roshni Banker Cariello – Davis Polk & Wardwell; Michael Farber – Davis Polk & Wardwell; Marcie Goldstein – Davis Polk & Wardwell; Lia-Michelle Keane – Davis Polk & Wardwell; Deanna Kirkpatrick – Davis Polk & Wardwell; Gil Savir – Davis Polk & Wardwell; Eitan Ulmer – Davis Polk & Wardwell;